Stacy C. Brecht

About Stacy C. Brecht

I’m a commercially minded, access-driven executive with deep expertise at the intersection of oncology, radiopharmaceuticals, and rare diseases. With 20+ years of progressive leadership across market access, pricing, commercialization, and radiopharmaceuticals. I’ve built and led high-impact teams, transformed complex pipelines into launch-ready assets, and unlocked access for life-changing therapies in some of the most complex healthcare environments.My passion lies in creating the infrastructure and strategies that turn scientific innovation into patient outcomes. From field team buildouts and payer negotiations to HEOR, global pricing, and HUB services, I bring a cross-functional mindset that aligns regulatory, clinical, and commercial priorities to one common goal: access without compromise.What sets me apart is my end-to-end experience—spanning diagnostics, theranostics, nuclear medicine, and biologics—combined with an operator’s instinct and a builder’s discipline. I thrive in high-stakes, launch-phase environments where urgency, ethics, and patient focus are non-negotiable.Trusted by C-suites, investors, and global partners, I serve as a strategic integrator and executional lead—delivering measurable value across the access continuum while navigating the complexities of payer policy, provider behavior, and patient affordability.Let’s connect if you’re building something bold, meaningful, and disruptive in healthcare access.

Experience

1. Director Pricing and Market Access

   ITM Isotope Technologies Munich SE

   Feb 2022 — Present · US

   Develop US Pricing and Market Access strategy for new diagnostic and therapeutic oncologic radiopharmaceutical products. Lead the development and implementation of all initiatives including the value and access, list, and net pricing strategies in collaboration with commercial contracting, and overall access to key payer archetypes. Develop and communicate market access strategies and plans in alignment with the overall brand plan. Contribute to the strategic direction of all brand planning activities through active participation with the senior leadership team across the ITM Portfolio. Responsibility for all pre-launch research and communication to senior leadership. Team outputs as well as key trends in pharmaceutical industry pricing, reimbursement, and market access, and develop proactive strategies in anticipation of these trends. Recommend and implement various market access initiatives to collect and integrate payer/market insights to inform brand strategy. Responsible for providing input to all product development teams by informing them of pricing and market access potential. Present payer issues, opportunities, and recommendations to leadership stakeholders. Responsible for building, developing, and coaching full market access team. Proven ability to communicate ideas and information both verbally and written in a persuasive and appropriate manner to all levels within the organization. Work closely with finance, analytics, and patient services teams to identify and address product barriers to payer access and performance by applying an advanced understanding of, and experience with strategies and payer analytics. Track ongoing US policy changes and provide readouts of impact scenarios to align with strategy recommendations. Manage market access launch budget and develop metrics to measure ROI against key initiatives. Collect data and evidence to support products globally.

Education

• CCAC

  Associate of Science (A.S.), Medical Laboratory Science

  2001 — 2003

• Bellevue University

  Master of Business Administration - MBA, Business Administration and Management, General

• Bellevue University

  Bachelor of Science (B.S.), Information Technology

  2017 — 2019

• CCAC

  Certificate Nuclear Medicine, Nuclear Medicine

  2003 — 2004

• CCAC

  Computed Tomography

  2014 — 2015